Brief exposure for PTSD in combat veterans
Part of Mental health clinical trials.
This study tests a very brief exposure therapy to help U.S. combat veterans with PTSD. It is designed for veterans who have not had recent mental health treatment and experienced combat trauma within the last 10 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a U.S. combat veteran between 18 and 50 years old.
- You have been diagnosed with PTSD, and your trauma happened during combat.
- Your combat trauma happened less than 10 years ago.
- You have not had treatment for PTSD, substance abuse, or other mental health concerns in the past 6 months.
- You do not have a history of traumatic brain injury, psychosis, bipolar disorder, or certain medical conditions (like epilepsy or cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a way to help reduce PTSD symptoms in first responders and frontline healthcare workers. You may join a main treatment study, and some participants may also take part in follow-up questions to learn what helped.
This trial studies how a therapy called “prolonged exposure” works for people with post-traumatic stress disorder (PTSD). You may be able to join if you have PTSD, are interested in starting prolonged exposure, and meet other safety and participation rules.
This study tests a short, focused therapy (SEE FAR CBT) for adults with PTSD. It's a type of talk therapy that helps you process trauma, and the study wants to see if it works better than the usual care you would get.
This study tests if a 10-week written exposure therapy program, delivered by behavioral health technicians, can help active duty military personnel with PTSD. It may help you process traumatic events in a structured, supportive way.
This trial tests a short therapy called BWRT (BrainWorking Recursive Therapy) to help people with PTSD. It compares the therapy to a waitlist group to see if it reduces trauma symptoms.
This trial tests if prolonged exposure therapy, a common PTSD treatment, can help people who also have a psychotic disorder (like schizophrenia or bipolar with psychosis). The goal is to reduce PTSD symptoms.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.